Keywords: Clinical trials, Off-label marketing, Antipsychotics, USA

New studies on Rx drugs: clinical trials reporting; off-label marketing; and use of antipsychotics

Article | 05 December 2011

US federal rules and regulations related to transparency of prescription drug studies and prohibitions on off-label marketing are the focus ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in